| Market Capitalization (Millions $) |
- |
| Shares
Outstanding (Millions) |
170 |
| Employees |
341 |
| Revenues (TTM) (Millions $) |
183 |
| Net Income (TTM) (Millions $) |
40 |
| Cash Flow (TTM) (Millions $) |
6 |
| Capital Exp. (TTM) (Millions $) |
19 |
Business Description
Antares Pharma Inc is a pharmaceutical company headquartered in Ewing, New Jersey. The company focuses on the development and commercialization of self-administered injectable pharmaceuticals. Antares Pharma specializes in developing innovative drug delivery systems that provide patients with more comfortable and convenient ways to administer medication.
Antares Pharma's product portfolio includes multiple self-injection devices and technologies, including the VIBEX QuickShot, a reusable autoinjector, and the OTREXUP, a single-dose, disposable autoinjector for the treatment of rheumatoid arthritis and psoriasis.
The company's technology platform has also been used to develop injectable products for the treatment of osteoporosis, multiple sclerosis, and testosterone replacement therapy. In addition, Antares Pharma has partnerships with several pharmaceutical companies to develop new products using its technology platform. The company also licenses its technology to third-party partners for use in developing new products.
Antares Pharma has a strong focus on research and development, investing heavily in clinical programs that help assess the efficacy and safety of its products. The company's research and development programs are focused on developing products for conditions with significant unmet medical needs, including chronic pain, diabetes, and central nervous system disorders.
Antares Pharma has a strong financial position, with a robust balance sheet and significant cash reserves that allow the company to pursue its research and development initiatives without the need for external financing.
Overall, Antares Pharma is a growing pharmaceutical company with a focus on developing innovative drug delivery systems that provide patients with more comfortable and convenient ways to administer medication. With a strong commitment to research and development, the company is well-positioned to develop new products and technologies that can address the significant unmet medical needs of patients around the world.
Company Address: 100 Princeton South Ewing 8628 NJ
Company Phone Number: 359-3020 Stock Exchange / Ticker: NASDAQ ATRS
|
%